The efficacy and safety of bevacizumab combined with chemotherapy in treatment of HER2-negative metastatic breast cancer: a meta-analysis based on published phase III trials

Tumor Biology ◽  
2014 ◽  
Vol 36 (3) ◽  
pp. 1933-1941 ◽  
Author(s):  
Yuan Fang ◽  
Xinlan Qu ◽  
Boran Cheng ◽  
Yuanyuan Chen ◽  
Zhenmeng Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Meta Analysis ◽  
Metastatic Breast ◽  
Phase Iii ◽  
Efficacy And Safety ◽  
Phase Iii Trials

Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer

2010 ◽  
Vol 36 (5) ◽  
pp. 410-415 ◽  
Author(s):  
Eitan Amir ◽  
Alberto Ocaña ◽  
Bostjan Seruga ◽  
Orit Freedman ◽  
Mark Clemons
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Meta Analysis ◽  
Metastatic Breast ◽  
Phase Iii ◽  
Her2 Status ◽  
Phase Iii Trials

scholarly journals Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

2011 ◽  
Vol 138 (2) ◽  
pp. 221-229 ◽  
Author(s):  
Maurizio Belfiglio ◽  
◽  
Caterina Fanizza ◽  
Nicola Tinari ◽  
Corrado Ficorella ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Meta Analysis ◽  
Metastatic Breast ◽  
Phase Iii ◽  
Phase Iii Trials

scholarly journals Efficacy and Safety of Everolimus in the Treatment of Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

2018 ◽  
Vol 21 ◽  
pp. S15
Author(s):  
RK Hyderboini ◽  
R Thode ◽  
M Malode ◽  
V Pinigani ◽  
J Nathani ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Metastatic Breast Cancer ◽  
Meta Analysis ◽  
Metastatic Breast ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document